Evidence map›Paper›PMID 42131974›Full record

ArticleBioelectromagnetics2026

Evaluation of the Effects of 50 Hz Magnetic Field Exposure on the Human Hematopoietic System in Humanized Mice.

Masayuki Takahashi, Izumi Nishimura, Toshihiko Toda

Abstract read
In one paragraph

Article in Bioelectromagnetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Masayuki TakahashiSustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), Chiba, Japan.ORCID https://orcid.org/0000-0002-3943-0783
Izumi NishimuraSustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), Chiba, Japan.
Toshihiko TodaJAC, Tokyo, Japan.

Funding

In-house budget
6 · The paper itself

Abstract

Accumulating evidence from experimental animal studies is essential for clarifying the causal relationship between exposure to power-frequency magnetic fields (MFs) and childhood leukemia. In this study, we developed a 50 Hz MF exposure system for experimental animals. To ensure uniform whole-body exposure of multiple animals placed at the center of the coil, we fabricated a Merritt-type coil. The maximum MF output inside the coil was 5 mT(rms), and spatial variation remained within ±2.5% of the target intensity. The system enabled stable exposure of experimental animals to uniform 50 Hz MFs while eliminating equipment-related artifacts. We then conducted exposure experiments using humanized mice, in which a human-like hematopoietic system was established by transplanting human hematopoietic stem and progenitor cells (HSPCs), to a 50 Hz, 5 mT(rms) MF for 2 months. After exposure, the chimerism rates of human leukocytes in hematopoietic organs of the MF-exposed group were comparable to those in the control group. Furthermore, exposure to the 50 Hz MF did not affect early differentiation of human B cells in the bone marrow of humanized mice. These findings support our previous in vitro results and validate the use of humanized mice for evaluating the effects of power-frequency MFs on human hematopoiesis. This system is expected to evaluate the effects of 50 Hz MFs not only on normal human hematopoiesis in humanized mice but also under abnormal conditions such as preleukemic state induced by transplanting genetically modified HSPCs.

Indexed as

HematopoiesisHematopoietic SystemMagnetic FieldsAnimalsCell DifferentiationHematopoietic Stem CellsHumansMicechildhood leukemiaextremely low‐frequency magnetic fieldhuman hematopoietic systemhumanized mice

Identifiers

PMID42131974
PMCPMC13173396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.